Statistics
Publications
17
Citations
2.3K
H-Index
15
Active since
1991
Paul Fleming is an author at Millennium Engineering and Integration (United States) specializing in life sciences, pharmacology, and biochemistry.
Publications per year
1991–2024
17
17
Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer
Erik Kupperman, Edmund C. Lee, Yueying Cao et al. · Cancer Research · 2010 · 493 citations
Medicine, Oncology, Pharmacology +13
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
Marc L. Hyer, Michael A. Milhollen, Jeff Ciavarri et al. · Nature Medicine · 2018 · 456 citations
Precision Targeted Therapy with BLU-667 for <i>RET</i>-Driven Cancers
Vivek Subbiah, Justin F. Gainor, Rami Rahal et al. · Cancer Discovery · 2018 · 393 citations
Medicine, Oncology, Pharmacology +17
1–5 of 17